Healthcare for all must be built on the voices of all

The state of health care in India is far from optimal, a statement with which few of its 1.3 billion citizens would disagree. Even prior to the pandemic, reforming the health system was overdue, evidenced by poor health indicators, unequal delivery of quality care and inadequate protection from financial risk. Despite significant improvements in areas … Continue reading Healthcare for all must be built on the voices of all

World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

Biocon Executive Chairperson Kiran Mazumdar-Shaw recently spoke at Carnegie India’s Global Technology Summit, which convened leading policymakers, entrepreneurs, industry leaders, academics and technologists from around the world to deliberate over five days on an overarching theme of ‘Geopolitics of Technology’. On Dec. 18, 2020, the last day of the summit, Ms Mazumdar-Shaw joined Soumya Swaminathan, … Continue reading World needs to balance risks, benefits and challenges of deploying COVID-19 vaccines

Fostering MedTech Innovation in India

India's first corporate hospital-based technology business incubator for MedTech entrepreneurs - the Mazumdar Shaw Medical Foundation (MSMF) MedTech Innovation Center - was inaugurated at Narayana Health City Bangalore, in collaboration with BIRAC, Bionest program, on Dec 15, 2020. Launching the facility, Ms. Kiran Mazumdar-Shaw, founder of MSMF and Executive Chairperson, Biocon said the centre will … Continue reading Fostering MedTech Innovation in India

India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says

India has the ability to aggressively ramp up coronavirus testing capacity, a move that will help it check a wave of new active cases hitting hospitals and skirt an economically unviable lockdown, according to Ms. Kiran Mazumdar-Shaw, the founder and chairman of Biocon Ltd.  With pooled testing that can include as many as 10 people in one … Continue reading India Has Potential to Increase Covid Testing 10-Fold, Kiran Mazumdar-Shaw Says

Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents/Day for LMICs

Kiran Mazumdar Shaw speaks at the UNAIDS Health Innovation Exchange Meeting on the sidelines of United Nations General Assembly, held in New York on 25th September 2019. Your Excellencies, Distinguished Ladies and Gentlemen, We have just witnessed the first UN High Level meeting on Universal Health Care on Monday. Governments have a collective moral responsibility … Continue reading Kiran Mazumdar-Shaw Promises to Enable Universal Access to rh-Insulin by Reducing Prices to Less than 10 US cents/Day for LMICs

Blueprint for a healthy India: Ayushman Bharat must tackle several challenges if it is to deliver tangible health benefits on scale

By Kiran Mazumdar Shaw A healthy India is a wealthy India. For an emerging economic superpower, health of its people is critical for economic productivity. Ayushman Bharat, which recently completed a year of existence, was conceptualised as an insurance based, healthcare delivery model that dovetails both preventive and curative healthcare at a coverage of Rs … Continue reading Blueprint for a healthy India: Ayushman Bharat must tackle several challenges if it is to deliver tangible health benefits on scale

Balancing Patient Convenience with Environmental Protection

Kiran Mazumdar –Shaw, CMD Biocon There are nearly half a billion diabetes patients in the world today and by 2040 that number is expected to climb to over 640 million. Even as diabetes incidence grows across the globe, developed markets like the U.S. are grappling with astronomical prices of one of the key medications for … Continue reading Balancing Patient Convenience with Environmental Protection

My address to Biocon Women Employees on International Women’s Day 2019

Today, as the first women employee of Biocon, I celebrate a lot of things done right at Biocon in last 40 years. When I started Biocon in 1978, there were very few women keen in business space.  I was perhaps the first tech startup in India because IT came to India a little later after … Continue reading My address to Biocon Women Employees on International Women’s Day 2019

A Journey of Endurance

By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance